Alex C. Spyropoulos, MD received his medical degree from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, PA. He completed his internship and residency in internal medicine at the University of New Mexico Health Sciences Center in Albuquerque, NM. He is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell and System Director of Anticoagulation and Clinical Thrombosis Services for the multi hospital Northwell Health System in New York, Professor of the Institute for Health Systems Science as part of the Feinstein Institutes for Medical Research, and Professor of the Elmezzi Graduate School of Molecular Medicine. He is Honorary Professor of Medicine at the University of Thessaly in Larissa, Greece. He has founded the Broxmeyer Fellowship in Clinical Thrombosis at the Feinstein Institutes for advanced training in the area of clinical thrombosis and anticoagulant therapy. As a clinical trialist, he has deep expertise in leading landmark global randomized controlled trials that include National Institutes of Health initiatives in the United States in the area of anticoagulant therapy and thrombosis. He has chaired multiple international scientific and guideline committees on the topic of thromboprophylaxis and perioperative use of anticoagulant therapy and has developed multiple teaching curricula on these topics. His expertise and that of his research team includes the development of risk models and clinical decision support systems either as stand-alone tools or integrated into cloud-based platforms (including the EvidencePoint platform that can be integrated agnostically into electronic health records of hospitalized patients).

As a Fulbright Scholar, Dr Spyropoulos will be teaching sections of the Advanced Post-Graduate Course on Thrombosis and Antithrombotic Therapy at the School of Medicine of the University of Thessaly, which he helped to develop. His research project includes the integration of a globally used venous thromboembolism clinical prediction tool for hospitalized medical patients that he developed called IMPROVE VTE into the electronic health records of the University Hospital of the University of Thessaly using the EvidencePoint platform. The project will assess rates of appropriate thromboprophylaxis and potential for improved clinical outcomes with the use of the tool, including assessing reductions in thrombosis.